Donor lymphocyte infusion and methotrexate for immune recovery after T‐cell depleted haploidentical transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|93|2|169-178

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.2, 2018-02, pp. : 169-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Viral‐specific T‐cell response in hemorrhagic cystitis after haploidentical donor stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 19, Iss. 6, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low‐dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 7, 2015-07 ,pp. : 594-605

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using αβ T cell–depleted grafts and the clinical implication of γδ T cells

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expansion of CD56-Negative, CD16-Positive, KIR-Expressing Natural Killer Cells after T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-03 ,pp. : 13-20

Karger

Access to resources Recommend Favorite

Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1493-1500

John Wiley & Sons Inc

Access to resources Recommend Favorite